In China, researchers found data that showed that the highest incidence of depression was found in the beta blocker and angiotensin-converting enzyme inhibitor classes of drugs.
When the underlying structural components of a functional predictor of the response to 5 Hz transcranial magnetic stimulation (TMS) for the treatment of posttraumatic stress disorder (PTSD) and major depressive disorder (MDD) are examined, the structural components of the anterior thalamic radiation account for significant variation in individual-level functional connectivity relationships that can predict posttreatment…
This is the first study to report an association between obstetric complications, atypical development, and aggressive behavior in first-episode psychosis.
Among other findings, investigators unexpectedly found that a protective function of schizophrenia liability contrasts with the effect of positive features.
In youth with moderate-to-severe depression, the addition of fluoxetine to cognitive behavioral therapy did not result in a further reduction in depressive symptoms.
A novel diagnostic biomarker for major depressive disorder has been proposed based on a highly specific pattern of reduced gray matter volume.
Investigators explored a link between elevated N-acetylaspartate concentrations and brain mechanisms in patients with persistent depressive disorder who were treated with duloxetine.
Researchers found that in patients with schizophrenia P3b might be a biomarker for clinical outcomes in psychosis risk syndrome.
In Denmark, investigators conducted twin studies determining no association between genetics and early environment with depression and ischemic heart disease.
Researchers found data that showed in older patients with schizophrenia that concurrently somatic serious adverse events occurred independent of treatment and due to treatment with antipsychotics.
